| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* HIV Immunopathogenesis Laboratory, Wistar Institute, and
Children’s Hospital of Philadelphia, Division of Immunologic and Infectious Diseases, Philadelphia, PA 19104;
Philadelphia Field Initiation Group for HIV Trials, Philadelphia, PA 19103; and
Laboratory for Immunological Research, Schering-Plough, Dardilly, France
Dendritic cells (DC) have an instrumental role in the activation
and function of both innate and adaptive immune responses. In humans,
at least two distinct DC subsets have been characterized based on
phenotypic markers: the myeloid DC (MDC) and the plasmacytoid DC (PDC).
Both subsets are critical producers of cytokines (IL-12 for MDC and
type I/II IFNs for PDC) and are functionally different. We show in this
study that HIV+ individuals have a significant decrease in
the number of the
Lin-HLA-DR+CD123+ and
BDCA-2+ PDC compared with uninfected donors
(p = 0.0001). HIV+ individuals also
have a sustained impairment in viral-induced IFN-
production
(p < 0.0001). The decrease of the PDC subsets did
not correlate with CD4 count or viral load and was not reversed in
subjects under virally suppressive treatment, suggesting an
irreversible change after infection. By contrast, the absolute number
and median frequency of MDC in HIV-infected individuals were similar to
those observed in uninfected controls, while a significant decrease was
present in subjects with >5000 HIV-1 copies/ml. The inverse
association with viral load of the MDC number, but not of IFN-
secretion or the number of PDC, suggests a role for MDC in viral
control. Our data suggest that DC subsets are differentially
reconstituted during the immune recovery associated with antiviral
therapy. The persistent impairment of certain DC subsets may result in
a sustained defect in DC-mediated innate immune functions despite an
effective treatment regimen.
This article has been cited by other articles:
|
|
 |
|
  B. Liu, A. M. Woltman, H. L. A. Janssen, and A. Boonstra Modulation of dendritic cell function by persistent viruses J. Leukoc. Biol., February 1, 2009; 85(2): 205 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Malleret, B. Maneglier, I. Karlsson, P. Lebon, M. Nascimbeni, L. Perie, P. Brochard, B. Delache, J. Calvo, T. Andrieu, et al. Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression Blood, December 1, 2008; 112(12): 4598 - 4608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Haupt, N. Donhauser, C. Chaipan, P. Schuster, B. Puffer, R. S. Daniels, T. C. Greenough, F. Kirchhoff, and B. Schmidt CD4 Binding Affinity Determines Human Immunodeficiency Virus Type 1-Induced Alpha Interferon Production in Plasmacytoid Dendritic Cells J. Virol., September 1, 2008; 82(17): 8900 - 8905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Jiang, M. M. Lederman, R. J. Mohner, B. Rodriguez, T. M. Nedrich, C. V. Harding, and S. F. Sieg Impaired Naive and Memory B-Cell Responsiveness to TLR9 Stimulation in Human Immunodeficiency Virus Infection J. Virol., August 15, 2008; 82(16): 7837 - 7845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sachdeva, V. Asthana, T. H. Brewer, D. Garcia, and D. Asthana Impaired Restoration of Plasmacytoid Dendritic Cells in HIV-1-Infected Patients with Poor CD4 T Cell Reconstitution Is Associated with Decrease in Capacity to Produce IFN-{alpha} but Not Proinflammatory Cytokines J. Immunol., August 15, 2008; 181(4): 2887 - 2897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. M. Diop, M. J.-Y. Ploquin, L. Mortara, A. Faye, B. Jacquelin, D. Kunkel, P. Lebon, C. Butor, A. Hosmalin, F. Barre-Sinoussi, et al. Plasmacytoid Dendritic Cell Dynamics and Alpha Interferon Production during Simian Immunodeficiency Virus Infection with a Nonpathogenic Outcome J. Virol., June 1, 2008; 82(11): 5145 - 5152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Tilton, M. M. Manion, M. R. Luskin, A. J. Johnson, A. A. Patamawenu, C. W. Hallahan, N. A. Cogliano-Shutta, J. M. Mican, R. T. Davey Jr., S. Kottilil, et al. Human Immunodeficiency Virus Viremia Induces Plasmacytoid Dendritic Cell Activation In Vivo and Diminished Alpha Interferon Production In Vitro J. Virol., April 15, 2008; 82(8): 3997 - 4006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fiorentini, E. Riboldi, F. Facchetti, M. Avolio, M. Fabbri, G. Tosti, P. D. Becker, C. A. Guzman, S. Sozzani, and A. Caruso HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype PNAS, March 11, 2008; 105(10): 3867 - 3872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.-x. Wang, J. Huang, H. Zhang, X. Ma, and H. Zhang APOBEC3G upregulation by alpha interferon restricts human immunodeficiency virus type 1 infection in human peripheral plasmacytoid dendritic cells J. Gen. Virol., March 1, 2008; 89(3): 722 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Tomescu, J. Chehimi, V. C. Maino, and L. J. Montaner NK Cell Lysis of HIV-1-Infected Autologous CD4 Primary T Cells: Requirement for IFN-Mediated NK Activation by Plasmacytoid Dendritic Cells J. Immunol., August 15, 2007; 179(4): 2097 - 2104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chehimi, L. Azzoni, M. Farabaugh, S. A. Creer, C. Tomescu, A. Hancock, A. Mackiewicz, L. D'Alessandro, S. Ghanekar, A. S. Foulkes, et al. Baseline Viral Load and Immune Activation Determine the Extent of Reconstitution of Innate Immune Effectors in HIV-1-Infected Subjects Undergoing Antiretroviral Treatment J. Immunol., August 15, 2007; 179(4): 2642 - 2650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. N. Brown, A. Trichel, and S. M. Barratt-Boyes Parallel Loss of Myeloid and Plasmacytoid Dendritic Cells from Blood and Lymphoid Tissue in Simian AIDS J. Immunol., June 1, 2007; 178(11): 6958 - 6967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Zhang, Z. Zhang, X. Wang, J.-L. Fu, J. Yao, Y. Jiao, L. Chen, H. Zhang, J. Wei, L. Jin, et al. PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors Blood, June 1, 2007; 109(11): 4671 - 4678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Yonkers, B. Rodriguez, K. A. Milkovich, R. Asaad, M. M. Lederman, P. S. Heeger, and D. D. Anthony TLR Ligand-Dependent Activation of Naive CD4 T Cells by Plasmacytoid Dendritic Cells Is Impaired in Hepatitis C Virus Infection J. Immunol., April 1, 2007; 178(7): 4436 - 4444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Teleshova, J. Kenney, G. Van Nest, J. Marshall, J. D. Lifson, I. Sivin, J. Dufour, R. Bohm, A. Gettie, and M. Robbiani Local and Systemic Effects of Intranodally Injected CpG-C Immunostimulatory-Oligodeoxyribonucleotides in Macaques J. Immunol., December 15, 2006; 177(12): 8531 - 8541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Urban, D. Cordery, M. J. Shafi, P. C. Bull, C. I. Newbold, T. N. Williams, and K. Marsh The Frequency of BDCA3-Positive Dendritic Cells Is Increased in the Peripheral Circulation of Kenyan Children with Severe Malaria Infect. Immun., December 1, 2006; 74(12): 6700 - 6706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chougnet and S. Gessani Role of gp120 in dendritic cell dysfunction in HIV infection J. Leukoc. Biol., November 1, 2006; 80(5): 994 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hosmalin and P. Lebon Type I interferon production in HIV-infected patients J. Leukoc. Biol., November 1, 2006; 80(5): 984 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Donaghy, J. Wilkinson, and A. L. Cunningham HIV interactions with dendritic cells: has our focus been too narrow? J. Leukoc. Biol., November 1, 2006; 80(5): 1001 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Plskova, K. Greiner, E. Muckersie, L. Duncan, and J. V. Forrester Interferon-{alpha}: A Key Factor in Autoimmune Disease? Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3946 - 3950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhang, J. Fu, Q. Zhao, Y. He, L. Jin, H. Zhang, J. Yao, L. Zhang, and F.-S. Wang Differential Restoration of Myeloid and Plasmacytoid Dendritic Cells in HIV-1-Infected Children after Treatment with Highly Active Antiretroviral Therapy J. Immunol., May 1, 2006; 176(9): 5644 - 5651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. URBAN, M. J. SHAFI, D. V. CORDERY, A. MACHARIA, B. LOWE, K. MARSH, and T. N. WILLIAMS FREQUENCIES OF PERIPHERAL BLOOD MYELOID CELLS IN HEALTHY KENYAN CHILDREN WITH {alpha}+ THALASSEMIA AND THE SICKLE CELL TRAIT Am J Trop Med Hyg, April 1, 2006; 74(4): 578 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Koelle, J. Huang, M. T. Hensel, and C. L. McClurkan Innate Immune Responses to Herpes Simplex Virus Type 2 Influence Skin Homing Molecule Expression by Memory CD4+ Lymphocytes J. Virol., March 15, 2006; 80(6): 2863 - 2872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zhang, J. D. Lifson, and C. Chougnet Failure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions Blood, March 1, 2006; 107(5): 1989 - 1995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Herbeuval, A. W. Hardy, A. Boasso, S. A. Anderson, M. J. Dolan, M. Dy, and G. M. Shearer Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: Role of type I IFN-producing plasmacytoid dendritic cells PNAS, September 27, 2005; 102(39): 13974 - 13979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Smed-Sorensen, K. Lore, J. Vasudevan, M. K. Louder, J. Andersson, J. R. Mascola, A.-L. Spetz, and R. A. Koup Differential Susceptibility to Human Immunodeficiency Virus Type 1 Infection of Myeloid and Plasmacytoid Dendritic Cells J. Virol., July 15, 2005; 79(14): 8861 - 8869. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hashizume, T. Horibe, H. Yagi, N. Seo, and M. Takigawa Compartmental Imbalance and Aberrant Immune Function of Blood CD123+ (Plasmacytoid) and CD11c+ (Myeloid) Dendritic Cells in Atopic Dermatitis J. Immunol., February 15, 2005; 174(4): 2396 - 2403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D C Baumgart, D Metzke, J Schmitz, A Scheffold, A Sturm, B Wiedenmann, and A U Dignass Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells Gut, February 1, 2005; 54(2): 228 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. McKenna, A.-S. Beignon, and N. Bhardwaj Plasmacytoid Dendritic Cells: Linking Innate and Adaptive Immunity J. Virol., January 1, 2005; 79(1): 17 - 27. [Full Text] [PDF]
|
|
|
|
|
|
K. B. Gurney, A. D. Colantonio, B. Blom, H. Spits, and C. H. Uittenbogaart Endogenous IFN-{alpha} Production by Plasmacytoid Dendritic Cells Exerts an Antiviral Effect on Thymic HIV-1 Infection J. Immunol., December 15, 2004; 173(12): 7269 - 7276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Teleshova, J. Kenney, J. Jones, J. Marshall, G. Van Nest, J. Dufour, R. Bohm, J. D. Lifson, A. Gettie, and M. Pope CpG-C Immunostimulatory Oligodeoxyribonucleotide Activation of Plasmacytoid Dendritic Cells in Rhesus Macaques to Augment the Activation of IFN-{gamma}-Secreting Simian Immunodeficiency Virus-Specific T Cells J. Immunol., August 1, 2004; 173(3): 1647 - 1657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Roy, G. Bandyopadhyay, S. Rakshit, M. Ray, and S. Bandyopadhyay IL-4 alone without the involvement of GM-CSF transforms human peripheral blood monocytes to a CD1adim, CD83+ myeloid dendritic cell subset J. Cell Sci., July 15, 2004; 117(16): 3435 - 3445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-F. Fonteneau, M. Larsson, A.-S. Beignon, K. McKenna, I. Dasilva, A. Amara, Y.-J. Liu, J. D. Lifson, D. R. Littman, and N. Bhardwaj Human Immunodeficiency Virus Type 1 Activates Plasmacytoid Dendritic Cells and Concomitantly Induces the Bystander Maturation of Myeloid Dendritic Cells J. Virol., May 15, 2004; 78(10): 5223 - 5232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Anthony, N. L. Yonkers, A. B. Post, R. Asaad, F. P. Heinzel, M. M. Lederman, P. V. Lehmann, and H. Valdez Selective Impairments in Dendritic Cell-Associated Function Distinguish Hepatitis C Virus and HIV Infection J. Immunol., April 15, 2004; 172(8): 4907 - 4916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fontana, D. Moratto, S. Mangal, M. De Francesco, W. Vermi, S. Ferrari, F. Facchetti, N. Kutukculer, C. Fiorini, M. Duse, et al. Functional defects of dendritic cells in patients with CD40 deficiency Blood, December 1, 2003; 102(12): 4099 - 4106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pichyangkul, T. P. Endy, S. Kalayanarooj, A. Nisalak, K. Yongvanitchit, S. Green, A. L. Rothman, F. A. Ennis, and D. H. Libraty A Blunted Blood Plasmacytoid Dendritic Cell Response to an Acute Systemic Viral Infection Is Associated with Increased Disease Severity J. Immunol., November 15, 2003; 171(10): 5571 - 5578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Poudrier, X. Weng, D. G. Kay, Z. Hanna, and P. Jolicoeur The AIDS-Like Disease of CD4C/Human Immunodeficiency Virus Transgenic Mice Is Associated with Accumulation of Immature CD11bHi Dendritic Cells J. Virol., November 1, 2003; 77(21): 11733 - 11744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chougnet Role of CD40 Ligand dysregulation in HIV-associated dysfunction of antigen-presenting cells J. Leukoc. Biol., November 1, 2003; 74(5): 702 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. T. H. Coates, S. M. Barratt-Boyes, L. Zhang, V. S. Donnenberg, P. J. O'Connell, A. J. Logar, F. J. Duncan, M. Murphey-Corb, A. D. Donnenberg, A. E. Morelli, et al. Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand Blood, October 1, 2003; 102(7): 2513 - 2521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Stebbing, B. Gazzard, S. Portsmouth, F. Gotch, L. Kim, M. Bower, S. Mandalia, R. Binder, P. Srivastava, and S. Patterson Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptor Blood, September 1, 2003; 102(5): 1806 - 1814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Bahr, X. De La Tribonniere, E. Darcissac, F. Ajana, L. Bocket, D. Sissoko, Y. Yazdanpanah, J. Dewulf, C. Amiel, and Y. Mouton Clinical and immunological effects of a 6 week immunotherapy cycle with murabutide in HIV-1 patients with unsuccessful long-term antiretroviral treatment J. Antimicrob. Chemother., June 1, 2003; 51(6): 1377 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Verthelyi, M. Gursel, R. T. Kenney, J. D. Lifson, S. Liu, J. Mican, and D. M. Klinman CpG Oligodeoxynucleotides Protect Normal and SIV-Infected Macaques from Leishmania Infection J. Immunol., May 1, 2003; 170(9): 4717 - 4723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kawamura, H. Gatanaga, D. L. Borris, M. Connors, H. Mitsuya, and A. Blauvelt Decreased Stimulation of CD4+ T Cell Proliferation and IL-2 Production by Highly Enriched Populations of HIV-Infected Dendritic Cells J. Immunol., April 15, 2003; 170(8): 4260 - 4266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. K. Choi, B. A. Fallert, M. A. Murphey-Corb, and T. A. Reinhart Simian immunodeficiency virus dramatically alters expression of homeostatic chemokines and dendritic cell markers during infection in vivo Blood, March 1, 2003; 101(5): 1684 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Bahr Non-specific immunotherapy of HIV-1 infection: potential use of the synthetic immunodulator murabutide J. Antimicrob. Chemother., January 1, 2003; 51(1): 5 - 8. [Full Text] [PDF]
|
|
|
|
|
|
M. Wysocka, M. H. Zaki, L. E. French, J. Chehimi, M. Shapiro, S. E. Everetts, K. S. McGinnis, L. Montaner, and A. H. Rook Sezary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines Blood, October 16, 2002; 100(9): 3287 - 3294. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
